Circular Genomics Raises $15M to Advance Circular RNA Platform for Alzheimer’s Detection
The financing will accelerate clinical validation and commercial readiness of brain-derived blood biomarkers based on circular RNA technology.
Read More
Search Results for: parkinson
New Genetic Test Targets Rare Movement Disorder
The targeted assay detects X-linked dystonia-parkinsonism cases that standard sequencing methods have missed.
Read More
Can AI Learn to Smell Disease? A New Dataset Paves the Way
Researchers are developing a large-scale olfactory dataset to train artificial intelligence, potentially unlocking smell as a powerful tool for early disease detection.
Read More
C2N Diagnostics Triples St. Louis Operations with New 82,000-Square-Foot Facility
The Alzheimer’s diagnostics company will relocate headquarters and expand CLIA-certified lab operations to the Cortex Innovation District by late 2026.
Read More
Investigational Blood Test Detects ALS Up to 10 Years Before Symptoms Appear
Johns Hopkins-led study identifies protein signature with 98% accuracy in distinguishing ALS patients from healthy individuals and those with other neurological diseases.
Read More